The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia


Çınarka H., GÜMÜŞ A., KARATAŞ M., KAYHAN S., KIRBAŞ A., ÖZYURT S., ...Daha Fazla

Advances in Bioscience and Clinical Medicine, cilt.3, sa.1, ss.10-16, 2014 (Hakemli Dergi)